About the lab

We integrate membrane biophysics, engineered extracellular vesicles, and neuroendocrine physiology to reveal mechanisms and build therapies for diabetes, neurodegeneration, and cancer.

Mission

We aim to decode the choreography of membrane fusion and to reprogram the cell-surface proteome using modular EV platforms.

Values

Scientific rigor and open science
Mentorship and inclusive excellence
Translational impact

Grants

NIH-NIGMS R35 (PI): Decoding the Molecular Choreography of Diverse Vesicle Release Mechanisms (2025–2030).
NIH-NIDDK R01 (PI): Molecular Determinants of Insulin Biphasic Secretion (2025–2030; scored below payline, pending council).
Yale Diabetes Disease Center Pilot Grant (PI): Distinct vesicle populations regulating insulin biphasic release (2024–2025).
Yale Pathology Pilot Grant (PI): VAMP1 in amyloid‑beta secretion in Alzheimer’s Disease (2023–2024).
Yale ADRC Pilot Grant (PI): Fusion proteins in synaptic dysfunction (2022–2023).

Awards & Honors

DRC Pilot Award (2024)
Blavatnik Award Quarter Finalist (2023)
ADRC Scholar Award (2022)
Academic Excellence in Engineering, Anna University (2003 & 2004)